Line clearance for production operations Review of BMR BFR BPR In - process QA functions Control sample management Collection of In process Finished product and customer samples Compilation of APQR data with trend analysis Participation in process validation hold time studies etc Co-ordination for batch release Routine GMP verification in production and warehouse production and all other departments Co-ordination and review of vendor management documents compilation of vendor assessment reports Document Archival management as on when required Issuance and control Formats SOPs Specifications and Batch Records In the three decades of its existence Piramal Group has pursued a twin strategy of both organic and inorganic growth Driven by its core values Piramal Group steadfastly pursues inclusive growth while adhering to ethical and values-driven practices Equal employment opportunityPiramal Group is proud to be an Equal Employment Opportunity and Affirmative Action employer We do not discriminate based upon race ethnicity religion color national origin gender including pregnancy childbirth or related medical conditions sexual orientation gender identity gender expression age status as a protected veteran status as an individual with a disability genetics or other applicable legally protected characteristics We base our employment decisions on merit considering qualifications skills performance and achievements We endeavor to ensure that all applicants and employees receive equal opportunity in personnel matters including recruitment selection training placement promotion demotion compensation and perks transfers terminations and working conditions including reasonable accommodation for qualified individuals with disabilities as well as individuals with needs related to their religious observance or practice Piramal Critical Care PCC under Piramal Pharma Limited PPL a subsidiary of Piramal Enterprises Limited is the third largest producer of Inhaled Anaesthetics and a global player in hospital generics Motivated by its vision to deliver critical care solutions for patients and healthcare providers across the globe PCC is committed to enabling sustainable and profitable growth for all its stakeholders PCC maintains a wide presence across the USA Europe and more than 100 countries across the globe Its rich product portfolio includes Inhalation Anaesthetics such as Sevoflurane Isoflurane and Halothane as well as Intrathecal Baclofen therapy for spasticity management PCC has wholly-owned state-of-the-art manufacturing facilities in the US and India that have successfully cleared periodical inspections by the US FDA UK MHRA and other regulators Its core strength lies in a highly qualified global workforce of more than 400 employees across 16 countries PCC is focused on further expanding its global footprint through new product additions in the critical care space Committed to corporate social responsibility alongside Piramal Group PCC collaborates with various partner organizations and proudly takes an active role in providing hope and resources to those in need as well as caring for the environment